Janux Therapeutics Inc
Biotechnology
Healthcare
JANX
61.79 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
23.62
52 week high
66.84
high
23.75
52 week low
0.00
low
22.79
growth
-54.22 %
previous Close
23.51
P/E ratio
market cap
1.37 B
div yield
0
net incoming
-23.51 M
-16.28 %
net profit margin
-2350800000.00 %
0.00 %
operating incoming
-34.90 M
-20.24 %
net change in cash
-356.86 M
-188.36 %
cash on hand
73.74 M
-82.87 %
top